All Stories

  1. Public Provision and Cross-Border Health Care

    Article • Forum for Health Economics & Policy, December 2016, De Gruyter

    PhD David Granlund

  2. Federal subsidization of state expenditure to reduce political budget cycles

    Article • International Tax and Public Finance, May 2016, Springer Science + Business Media

    PhD David Granlund

  3. Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose

    Article • International Journal of Health Economics and Management, February 2016, Springer Science + Business Media

    PhD David Granlund

  4. EU Enlargement, Parallel Trade and Price Competition in Pharmaceuticals: Has the Price Competition increased?

    Article • The B E Journal of Economic Analysis & Policy, January 2016, De Gruyter

    PhD David Granlund

  5. Gender norms, work hours, and corrective taxation

    Article • Journal of Behavioral and Experimental Economics, June 2015, Elsevier

    PhD David Granlund

  6. The Effect of Pharmacies’ Right to Negotiate Discounts on the Market Share of Parallel Imported Pharmaceuticals

    Article • The B E Journal of Economic Analysis & Policy, January 2015, De Gruyter

    PhD David Granlund

  7. Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?

    Article • The European Journal of Health Economics, November 2014, Springer Science + Business Media

    PhD David Granlund

  8. Introducing waiting times for health care in a labor supply model for sickness absence

    Article • Nordic Journal of Health Economics, August 2014, University of Oslo Library

    PhD David Granlund

  9. Present-Biased Preferences and Publicly Provided Private Goods

    Article • FinanzArchiv Public Finance Analysis, June 2014, Mohr Siebeck

    PhD David Granlund

  10. The Prescribing Physician’s Influence on Consumer Choice Between Medically Equivalent Pharmaceuticals

    Article • Review of Industrial Organization, February 2012, Springer Science + Business Media

    PhD David Granlund

  11. Public goods and optimal paternalism under present-biased preferences

    Article • Economics Letters, October 2011, Elsevier

    PhD David Granlund

  12. Price and welfare effects of a pharmaceutical substitution reform

    Article • Journal of Health Economics, December 2010, Elsevier

    PhD David Granlund

  13. Consumer Information and Pharmaceutical Prices: Theory and Evidence*

    Article • Oxford Bulletin of Economics and Statistics, November 2010, Wiley

    PhD David Granlund

  14. Electoral accountability in a country with two-tiered government

    Article • Public Choice, July 2010, Springer Science + Business Media

    PhD David Granlund

  15. The effect of health care expenditure on sickness absence

    Article • The European Journal of Health Economics, January 2010, Springer Science + Business Media

    PhD David Granlund

  16. Inequality in mortality in Vietnam during a period of rapid transition

    Article • Social Science & Medicine, January 2010, Elsevier

    Dr Phuc Ho Dang, PhD David Granlund

  17. Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals?

    Article • Social Science & Medicine, December 2009, Elsevier

    PhD David Granlund

  18. Sickness absence and health care in an economic federation

    Article • International Tax and Public Finance, April 2007, Springer Science + Business Media

    PhD David Granlund

  19. Fixed budgets as a cost containment measure for pharmaceuticals

    Article • The European Journal of Health Economics, March 2006, Springer Science + Business Media

    PhD David Granlund